Company Completes Committee Restructuring Following Key Director Changes
The Board of Directors of Indo Us Bio-Tech Ltd has approved the reconstitution of several key committees, effective July 10, 2026. This restructuring follows changes in the company's directorial composition.A meeting of the Board focused on finalizing the membership and roles within the Audit Committee, the Nomination and Remuneration Committee, and the Stakeholders Relationship Committee.
Updated Committee Memberships
The composition of the committees is as follows:Audit Committee
| SR.NO. | NAME | DESIGNATION |
|---|---|---|
| 1. | Ritaben Nileshbhai Kikani | Chairperson |
| 2. | Shilpa Chetanbhai Thumar | Member |
| 3. | Jagdishkumar Devjibhai Ajudiya | Member |
| 4. | Hemanshi Darsh Soni | Member |
Nomination and Remuneration Committee
| SR.NO. | NAME | DESIGNATION |
|---|---|---|
| 1. | Shilpa Chetanbhai Thumar | Chairperson |
| 2. | Ritaben Nileshbhai Kikani | Member |
| 3. | Hemanshi Darsh Soni | Member |
Stakeholders Relationship Committee
| SR.NO. | NAME | DESIGNATION |
|---|---|---|
| 1. | Ritaben Nileshbhai Kikani | Chairperson |
| 2. | Jagdishkumar Devjibhai Ajudiya | Member |
| 3. | Hemanshi Darsh Soni | Member |
| 4. | Shilpa Chetanbhai Thumar | Member |
Reason for Reconstitution
The need for committee reconstitution stemmed from the resignation of Mrs. Nehaben Patel from the office of Non-Executive Independent Director of the Company, which occurred on April 21, 2026.In response to this change, the Board had previously appointed Mrs. Hemanshi Darsh Soni as an Additional Director (Non-Executive, Independent) on the same date. The subsequent board meeting finalized the updated structures across the mentioned committees to ensure proper operational compliance.
GMMPFAUDLR Stock Price Movement
Today, GMM Pfaudler Limited shed 1.07% in post-market trading, settling at ₹754.5 after the close. The stock traded within a daily range of ₹750.05 to ₹774.80 during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.